Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAdvantex Pharma is a Canadian life sciences company specializing in the research, development, and commercialization of evidence-based nutraceuticals and pharmaceutical-grade health products. The company is primarily focused on urology and men's health, particularly in providing validated solutions for prostate health management. BioAdvantex is well-regarded for its commitment to clinical rigor, frequently collaborating with major academic institutions to conduct trials on its formulations. Their flagship product, PC-HOPE, was developed as a standardized and safe alternative for patients seeking natural support for prostate conditions. By bridging the gap between traditional pharmacology and natural medicine, BioAdvantex provides clinicians and patients with high-quality, research-backed therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAdvantex Pharma.